Potential years of life and productivity loss due to malignant mesothelioma in Turkey

References

• Bianchi C, Bianchi T. Global mesothelioma epidemic: trend and features. Indian J Occup Environ Med. 2014;18(2):82–88. doi:10.4103/0019-5278.146897.
   PubMedGoogle Scholar
• Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17(4):260–271. doi:10.1136/oem.17.4.260.
   PubMedGoogle Scholar
• McDonald JC. Epidemiology of malignant mesothelioma–an outline. Ann Occup Hyg. 2010;54:851–857. doi:10.1093/annhyg/meq076.
   PubMed Web of Science ®Google Scholar
• McDonald C, ed. Epidemiology of Work Related Diseases. London: BMJ Books; 2000.
   Google Scholar
• Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369(9564):844–849. doi:10.1016/S0140-6736(07)60412-7.
   PubMed Web of Science ®Google Scholar
• Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1:491–496. doi:10.3978/j.issn.2225-319X.2012.11.04.
   PubMedGoogle Scholar
• Park EK, Takahashi K, Jiang Y, et al. Elimination of asbestos use and asbestos-related diseases: An unfinished story. Cancer Sci. 2012;103(10):1751–1755. doi:10.1111/j.1349-7006.2012.02366.
   PubMed Web of Science ®Google Scholar
• Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56(8):505–513. doi:10.1136/oem.56.8.505.
   PubMed Web of Science ®Google Scholar
• Metintas S, Ak G, Metintas M. A review of the cohorts with environmental and occupational mineral fiber exposure. Arch Environ Occup Health. 2019;74(1–2):76–84. doi:10.1080/19338244.2018.1467873.
   PubMed Web of Science ®Google Scholar
• Metintas S, Metintas M, Ucgun I, Oner U. Malignant mesothelioma due to environmental exposure to asbestos. Chest. 2002;122(6):2224–2229.
   PubMed Web of Science ®Google Scholar
• Metintaş S, Batırel HF, Bayram H, et al. Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program. IJERPH. 2017;14(11):E1293. doi:10.3390/ijerph14111293.
   Google Scholar
• Kim JL, Cho KH, Park EC, Cho WH. A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev. 2014;15(1):433–439. doi:10.7314/APJCP.2014.15.1.433.
   PubMedGoogle Scholar
• Khorasani S, Rezaei S, Rashidian H, Daroudi R. Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran. Asian Pac J Cancer Prev. 2015;16(5):1845–1850. doi:10.7314/APJCP.2015.16.5.1845.
   PubMedGoogle Scholar
• Hanly PA, Sharp L. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer. 2014;14(1):224. doi:10.1186/1471-2407-14-224.
   PubMedGoogle Scholar
• The Global Economy and Turkey: an OECD perspective. Organisation for Economic Co-operation and Development. https://www.oecd.org/turkey/theglobaleconomyandturkeyanoecdperspective.htm. Accessed March 20, 2019.
   Google Scholar
• Statistics on unemployment and supplementary measures of labour underutilization. International Labour Organization. https://ilostat.ilo.org/topics/unemployment-and-labour-underutilization/. Accessed March 20, 2019.
   Google Scholar
• Murray C. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Org. 1994;72:429–445.
   PubMed Web of Science ®Google Scholar
• Hanly P, Soerjomataram I, Sharp L. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer. 2015;136(4):E136–E145. doi:10.1002/ijc.29105.
   PubMed Web of Science ®Google Scholar
• Steenland K, Armstrong B. An overview of methods for calculating the burden of disease due to specific risk factors. Epidemiology. 2006;17:512–519. doi:10.1097/01.ede.0000229155.05644.43.
   PubMed Web of Science ®Google Scholar
• Ortiz-Ortiz KJ, Pérez-Irizarry J, Marín-Centeno H, et al. Productivity loss in Puerto Rico's labor market due to cancer mortality. P R Health Sci J. 2010;29:241–249.
   PubMed Web of Science ®Google Scholar
• Najafi F, Karami-Matin B, Rezaei S, et al. Productivity costs and years of potential life lost associated with five leading causes of death: evidence from Iran (2006-2010). Med J Islam Repub Iran. 2016;30:412. eCollection 2016.
   PubMedGoogle Scholar
• Bang KM, Mazurek JM, Wood JM, Hendricks SA. Diseases attributable to asbestos exposure: years of potential life lost, United States, 1999–2010. Am J Ind Med. 2014;57(1):38–48. doi:10.1002/ajim.22261.
   PubMed Web of Science ®Google Scholar
• Carbone M, Ly BH, Dodson RF, et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227(1):44–58. doi:10.1002/jcp.22724.
   PubMed Web of Science ®Google Scholar
• Brustugun OT, Møller B, Helland A. Years of life lost as a measure of cancer burden on a national level. Br J Cancer. 2014;111(5):1014–1020. doi:10.1038/bjc.2014.364.
   PubMed Web of Science ®Google Scholar
• Rouse C, Gittleman H, Ostrom QT, et al. Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. Neuro Oncol. 2016;18(1):70–77. doi:10.1093/neuonc/nov249.
   PubMed Web of Science ®Google Scholar
• Metintas S, Ak G, Yilmaz S, et al. Validity and reliability of asbestos knowledge and awareness questionnaire for environmental asbestos exposure in rural areas. Eurasian J Pulmonol. 2017;19(1):34–40. doi:10.5152/ejp.2016.57441.
   Web of Science ®Google Scholar
• Metintas S, Ak G, Bogar F, et al. Asbestos knowledge and awareness level in central part of Anatolia. Int J Occup Environ Health. 2017;23(3):243–249. doi:10.1080/10773525.2018.1470789.
   PubMed Web of Science ®Google Scholar
• Şenyiğit A, Babayiğit C, Gökirmak M, et al. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey. Respiration. 2000;67(6):610–614. doi:10.1159/000056289.
   PubMed Web of Science ®Google Scholar
• Burnet NG, Jefferies SJ, Benson RJ, et al. Years of life lost (YLL) from cancer is an important measure of population burden––and should be considered when allocating research funds. Br J Cancer. 2005;92(2):241–245. doi:10.1038/sj.bjc.660232.
   PubMed Web of Science ®Google Scholar
• Ak G, Metintas S, Kose T, et al. The relationship between treatment cost and prognosis of malignant pleural mesothelioma in Turkey. Eurasian J Pulmonol. 2019;21:50–56. doi:10.4103/ejop.ejop_41_18.
   Web of Science ®Google Scholar